Corrigendum to "The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials" [Contemp. Clin. Trials Commun. 16 (2019) 100443]

Matthew Michelson¹, Katja Reuter^{2

3}

Affiliations

¹ Evid Science, 2361 Rosecrans Ave #348, El Segundo, 90245, Los Angeles, CA, United States.
² Institute for Health Promotion and Disease Prevention Research, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N, Soto St, Los Angeles, CA, 90032, United States.
³ Southern California Clinical and Translational Science Institute, Keck School of Medicine, University of Southern California, 2250 Alcazar, Los Angeles, CA, 90089, United States.

Published Erratum

Matthew Michelson et al. Contemp Clin Trials Commun. 2019.

. 2019 Sep 12:16:100450.

doi: 10.1016/j.conctc.2019.100450. eCollection 2019 Dec.

Matthew Michelson¹, Katja Reuter^{2

3}

¹ Evid Science, 2361 Rosecrans Ave #348, El Segundo, 90245, Los Angeles, CA, United States.
² Institute for Health Promotion and Disease Prevention Research, Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 2001 N, Soto St, Los Angeles, CA, 90032, United States.
³ Southern California Clinical and Translational Science Institute, Keck School of Medicine, University of Southern California, 2250 Alcazar, Los Angeles, CA, 90089, United States.

Abstract

[This corrects the article DOI: 10.1016/j.conctc.2019.100443.].

The significant cost of systematic reviews and meta-analyses: A call for greater involvement of machine learning to assess the promise of clinical trials.
Michelson M, Reuter K. Michelson M, et al. Contemp Clin Trials Commun. 2019 Aug 25;16:100443. doi: 10.1016/j.conctc.2019.100443. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31497675 Free PMC article.